Corbus Pharmaceuticals Holdings Inc (CRBP)
48.69
+1.89
(+4.04%)
USD |
NASDAQ |
Jun 04, 10:53
Corbus Pharmaceuticals Holdings 1 Year Total Returns (Daily): 375.1% for June 3, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| June 03, 2024 | 375.1% |
| May 31, 2024 | 352.0% |
| May 30, 2024 | 367.9% |
| May 29, 2024 | 338.5% |
| May 28, 2024 | 330.3% |
| May 24, 2024 | 309.3% |
| May 23, 2024 | 279.3% |
| May 22, 2024 | 304.7% |
| May 21, 2024 | 316.6% |
| May 20, 2024 | 347.5% |
| May 17, 2024 | 336.0% |
| May 16, 2024 | 340.1% |
| May 15, 2024 | 320.4% |
| May 14, 2024 | 336.9% |
| May 13, 2024 | 335.7% |
| May 10, 2024 | 361.8% |
| May 09, 2024 | 393.1% |
| May 08, 2024 | 318.5% |
| May 07, 2024 | 278.4% |
| May 06, 2024 | 269.4% |
| May 03, 2024 | 356.1% |
| May 02, 2024 | 376.3% |
| May 01, 2024 | 339.3% |
| April 30, 2024 | 321.9% |
| April 29, 2024 | 305.9% |
| Date | Value |
|---|---|
| April 26, 2024 | 345.4% |
| April 25, 2024 | 271.8% |
| April 24, 2024 | 249.5% |
| April 23, 2024 | 326.9% |
| April 22, 2024 | 326.5% |
| April 19, 2024 | 289.7% |
| April 18, 2024 | 204.4% |
| April 17, 2024 | 255.3% |
| April 16, 2024 | 328.8% |
| April 15, 2024 | 345.5% |
| April 12, 2024 | 398.2% |
| April 11, 2024 | 387.8% |
| April 10, 2024 | 381.1% |
| April 09, 2024 | 383.5% |
| April 08, 2024 | 418.2% |
| April 05, 2024 | 425.9% |
| April 04, 2024 | 461.5% |
| April 03, 2024 | 501.6% |
| April 02, 2024 | 415.3% |
| April 01, 2024 | 422.6% |
| March 28, 2024 | 426.7% |
| March 27, 2024 | 421.6% |
| March 26, 2024 | 427.7% |
| March 25, 2024 | 420.1% |
| March 22, 2024 | 424.6% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-89.53%
Minimum
Oct 19 2022
1.99K%
Maximum
Mar 13 2024
5.58%
Average
-33.87%
Median
Feb 19 2020
1 Year Total Returns (Daily) Benchmarks
| AIM ImmunoTech Inc | -20.67% |
| Perspective Therapeutics Inc | 151.4% |
| Protalix BioTherapeutics Inc | -47.96% |
| Electromed Inc | 23.71% |
| Armata Pharmaceuticals Inc | 70.81% |